<!DOCTYPE html>
<html>
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
  </head>
  <body>
    <p>What she said.<br>
    </p>
    <div class="moz-cite-prefix">On 2/8/2024 10:57 AM, Krista Jacobsen
      via Patentpractice wrote:<br>
    </div>
    <blockquote type="cite"
cite="mid:CAN7twq2LJ9c03cBGMK4LOZscQGuF+faoKiYP0j=vBDL5CLBTEA@mail.gmail.com">
      <meta http-equiv="content-type" content="text/html; charset=UTF-8">
      <div dir="ltr">
        <div>Great letter, as always, Carl.</div>
        <div><br>
        </div>
        <div>A related issue is exactly which of the various documents
          in the DOCX cluster*$%@ is the authoritative document. I have
          not been able to figure this out, and the USPTO has put out
          inconsistent information.<br>
        </div>
        <div><br>
        </div>
        <div>Using Carl's terminology, there are potentially four
          documents in the mix (as opposed to the single document in the
          PDF filing path, which leaves no doubt as to the authoritative
          version of the written description, claims, and abstract):</div>
        <div><br>
        </div>
        <div>D1 = applicant-generated/uploaded DOCX file (discarded
          during filing process)<br>
          P1 = applicant-generated/uploaded auxiliary PDF file
          (optional)<br>
          D2 = USPTO-generated DOCX file ("validated DOCX file")<br>
          P2 = USPTO-generated PDF file (presumably generated from D2,
          but has the USPTO ever said this?)<br>
        </div>
        <div><br>
        </div>
        <div>Which one is the authoritative document?</div>
        <div><br>
        </div>
        <div>It is obviously not D1, which the USPTO discards during the
          filing process.</div>
        <div><br>
        </div>
        <div>Is D2 the authoritative document? The USPTO said it is in
          the Apr 28, 2022 FR Notice: "the USPTO considers the validated
          DOCX file(s) submitted by the applicant to be the
          authoritative document and that applicants may rely on the
          validated DOCX file(s) as the source or evidentiary copy of
          the application to make any corrections to the documents in
          the application file."</div>
        <div><br>
        </div>
        <div>Setting aside the planet-sized elephant in the room, namely
          that what the USPTO sees on its computers using its word
          processing software when it opens this file might be different
          from what I see on my computer using my word processing
          software when I open this file, the USPTO said in the Jun 2,
          2021 FR Notice that D2 might disappear from the file wrapper
          after a year: “the USPTO has a records retention schedule for
          documents it receives, including new patent applications and
          correspondence filed in patent applications. . . . In 2011,
          the USPTO established a one-year retention policy for
          patent-related papers scanned into the IFW or SCORE. . . . <u>After
            the expiration of the one-year period, the USPTO disposes of
            the paper</u> unless the applicant, patent owner, or
          reexamination party timely files a bona fide request to
          correct the electronic record of the paper in IFW or SCORE. <u>DOCX
            submissions will be treated similarly</u>.”</div>
        <div><br>
        </div>
        <div>I am not aware of any retraction of this policy, so I
          assume it still applies.<br>
        </div>
        <div><br>
        </div>
        <div>If D2 is "disposed of" before the application has been
          examined, how can D2 possibly be the authoritative document,
          given that the application probably hasn't been examined one
          year after filing? If D2 is gone from the record by the time
          the examiner picks up the application, what does the examiner
          look at? It seems to me that despite what the USPTO has said
          on the subject, D2 cannot be the authoritative version, at
          least not after a year from the filing date.<br>
        </div>
        <div><br>
        </div>
        <div>Thus, we are left with P1 and P2 as the only remaining
          options.</div>
        <div><br>
        </div>
        <div>P1 SHOULD be, but sadly cannot be, the authoritative
          document because the applicant is not required to submit it. <br>
        </div>
        <div><br>
        </div>
        <div>This leaves P2 as the only remaining possibility. But after
          saying that P2 is the authoritative version, the USPTO walked
          it back in the Apr 28, 2022 FR Notice and explicitly said P2
          is not the authoritative version: "The USPTO previously stated
          that for applications filed in DOCX, the authoritative
          document would be the accompanying PDF that the USPTO systems
          generate from the DOCX document. In response to public
          feedback, however, the USPTO now considers the DOCX document
          filed by the applicant to be the authoritative document."</div>
        <div><br>
        </div>
        <div>What a mess.<br>
        </div>
        <div><br>
        </div>
        <div>
          <div>Hello, USPTO: </div>
          <div><br>
          </div>
          <div>(1) If D2 is the authoritative document, it MUST remain
            in the file wrapper for the life of the patent plus the PTA
            period plus the entire post-expiration enforcement period.
            Also, please acknowledge that what USPTO personnel see when
            they open D2 is not necessarily what I see when I open D2,
            and that is a key reason why essentially nobody in the
            practitioner/applicant community thinks DOCX filing is a
            good idea.<br>
          </div>
          <div>(2) If P2 is the authoritative document, the USPTO needs
            to reverse itself again and say so.</div>
          <div>(3) The way out of this mess is to make P1 the
            authoritative document and ask nicely for applicants to
            submit a DOCX file.<br>
          </div>
          <div><br>
          </div>
          <div>Best regards,</div>
          <div>Krista<br>
          </div>
          <div><br>
          </div>
          <div>
            <div>
              <div>
                <div dir="ltr" class="gmail_signature"
                  data-smartmail="gmail_signature">
                  <div dir="ltr">
                    <div>
                      <div dir="ltr">
                        <div>------------------------------------------<br>
                        </div>
                        <div>Krista S. Jacobsen<br>
                        </div>
                        <div>Attorney and Counselor at Law</div>
                        <div>Jacobsen IP Law</div>
                        <div><a href="mailto:krista@jacobseniplaw.com"
                            target="_blank" moz-do-not-send="true"
                            class="moz-txt-link-freetext">krista@jacobseniplaw.com</a></div>
                        <div>T:  408.455.5539</div>
                        <div><a href="http://www.jacobseniplaw.com"
                            target="_blank" moz-do-not-send="true">www.jacobseniplaw.com</a></div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <br>
            </div>
          </div>
        </div>
      </div>
      <br>
      <div class="gmail_quote">
        <div dir="ltr" class="gmail_attr">On Thu, Feb 8, 2024 at 2:50 AM
          Carl Oppedahl via Patentpractice <<a
            href="mailto:patentpractice@oppedahl-lists.com"
            moz-do-not-send="true" class="moz-txt-link-freetext">patentpractice@oppedahl-lists.com</a>>
          wrote:<br>
        </div>
        <blockquote class="gmail_quote"
style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
          <div>
            <p><span
style="color:rgb(51,51,51);font-family:"Libre Franklin","Helvetica Neue",helvetica,arial,sans-serif;font-size:16px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;word-spacing:0px;white-space:normal;background-color:rgb(255,255,255);text-decoration-style:initial;text-decoration-color:initial;display:inline;float:none">The
                urgent question outstanding for those who file utility
                patent applications at the USPTO is, are they stuck with
                no choice but to pay the $400 penalty to preserve the
                safe and trusted legacy PDF filing path, or is there any
                chance that the “DOCX with auxiliary PDF” path might
                present an acceptable level of professional liability
                risk so that the client could avoid the $400 penalty? 
                Maybe the USPTO will clarify this. <br>
              </span></p>
            <p><span
style="color:rgb(51,51,51);font-family:"Libre Franklin","Helvetica Neue",helvetica,arial,sans-serif;font-size:16px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;word-spacing:0px;white-space:normal;background-color:rgb(255,255,255);text-decoration-style:initial;text-decoration-color:initial;display:inline;float:none">See
                <a
href="https://blog.oppedahl.com/maybe-uspto-will-clarify-the-docx-safeguard/"
                  target="_blank" moz-do-not-send="true"
                  class="moz-txt-link-freetext">https://blog.oppedahl.com/maybe-uspto-will-clarify-the-docx-safeguard/</a>
                .<br>
              </span></p>
            <p><span
style="color:rgb(51,51,51);font-family:"Libre Franklin","Helvetica Neue",helvetica,arial,sans-serif;font-size:16px;font-style:normal;font-variant-ligatures:normal;font-variant-caps:normal;font-weight:400;letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;word-spacing:0px;white-space:normal;background-color:rgb(255,255,255);text-decoration-style:initial;text-decoration-color:initial;display:inline;float:none"><br>
              </span></p>
          </div>
          -- <br>
          Patentpractice mailing list<br>
          <a href="mailto:Patentpractice@oppedahl-lists.com"
            target="_blank" moz-do-not-send="true"
            class="moz-txt-link-freetext">Patentpractice@oppedahl-lists.com</a><br>
          <a
href="http://oppedahl-lists.com/mailman/listinfo/patentpractice_oppedahl-lists.com"
            rel="noreferrer" target="_blank" moz-do-not-send="true"
            class="moz-txt-link-freetext">http://oppedahl-lists.com/mailman/listinfo/patentpractice_oppedahl-lists.com</a><br>
        </blockquote>
      </div>
      <br>
      <fieldset class="moz-mime-attachment-header"></fieldset>
    </blockquote>
  </body>
</html>